Dr. Jaskirn Kaur Dhillon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 350 Walters Rd, Suisun City, CA 94585 Phone: 707-580-4580 |
Dr. Irving Robert Veilleux, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 350 Walters Rd, Suisun City, CA 94585 Phone: 707-639-4982 Fax: 707-639-4983 |
Dr. Anh-tu Dinh Nguyen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1776 Dover Cir, Suisun City, CA 94585 Phone: 626-235-9932 |
Victor Alexander Chirkin, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 270 Sunset Ave, Suisun City, CA 94585 Phone: 707-426-1274 Fax: 707-426-3280 |
Navreet Goswami Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 135 Sunset Ave, Suisun City, CA 94585 Phone: 707-426-4242 |
Linda Dangtran, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 270 Sunset Ave, Suisun City, CA 94585 Phone: 707-426-1274 Fax: 707-426-3280 |
Kim Inez Jackson-hodge, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 350 Walters Rd, Suisun City, CA 94585 Phone: 707-639-4982 Fax: 707-639-4983 |
Mr. Enrico Hoganas Dizon Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1726 Altus Ln, Suisun City, CA 94585 Phone: 707-427-8680 |
Rami Kamal Saad, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 135 Sunset Ave, Suisun City, CA 94585 Phone: 707-426-4242 Fax: 707-426-4058 |
Emma Concepcion Santero Parayno, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 135 Sunset Ave, Suisun City, CA 94585 Phone: 707-426-4242 |
News Archive
Today, the U.S. Food and Drug Administration authorized marketing of the GI Genius, the first device that uses artificial intelligence (AI) based on machine learning to assist clinicians in detecting lesions (such as polyps or suspected tumors) in the colon in real time during a colonoscopy.
University of Delaware scientist Donald Watson is part of a research team that has discovered an easier method for incorporating fluorine into organic molecules, giving chemists an important new tool in developing materials ranging from new medicines to agricultural chemicals.
Neuralstem, Inc. (NYSE Amex: CUR) today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to commence a Phase I trial to treat Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) with its spinal cord stem cells.
Minnesota Public Radio reports: "Sen. Amy Klobuchar, [D-Minn.] says she hopes to include legislation to prevent Medicare fraud in the health reform bill being debated in Washington.
It is well known that adverse drug reactions and medication errors cause increased morbidity. But the cost for society may be underestimated. This is shown in a review of the literature, conducted at the Nordic School of Public Health NHV.
› Verified 5 days ago